Literature DB >> 12618963

Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

Muddassar M Mirza1, Sheila A Fisher, Kathy King, Andrew P Cuthbert, Jochen Hampe, Jeremy Sanderson, John Mansfield, Peter Donaldson, Andrew J S Macpherson, Alastair Forbes, Stefan Schreiber, Cathryn M Lewis, Christopher G Mathew.   

Abstract

A common haplotype spanning 250 kb in the cytokine gene cluster on chromosome 5q31 has recently been reported to be strongly associated with Crohn disease (CD) in Canadian families. We have replicated this finding by both the transmission-disequilibrium test (TDT) (P=.016) and in a case-control association study (P=.008) in a large European cohort of patients with CD, although the increase in disease risk was small (odds ratio 1.49 for homozygotes, 95% CI 1.11-2.0). No association was detected in families or individuals with ulcerative colitis (UC). Stratification of offspring with CD in the TDT sample by mutation status in the CD susceptibility gene CARD15 showed that the association with the 5q31 risk haplotype was present only in offspring with at least one of the known CARD15 disease susceptibility alleles (P=.044). The 5q31 risk haplotype frequency was 53.1% in unrelated individuals with CD who had one or two CARD15 mutations versus 43.7% in control subjects (P=.0001) but was not significantly elevated in individuals with CD who had no CARD15 mutations (45.4%, P=.41). Kaplan-Meier survival analysis of age at disease onset showed a significantly earlier onset in homozygotes for the 5q31 risk haplotype (P=.0019). These findings suggest that genetic variants at the 5q31 (IBD5) locus may hasten the onset of Crohn disease and cooperate with CARD15 in disease causation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618963      PMCID: PMC1180331          DOI: 10.1086/373880

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Parameters for reliable results in genetic association studies in common disease.

Authors:  Ingrid Dahlman; Iain A Eaves; Roman Kosoy; V Anne Morrison; Joanne Heward; Stephen C L Gough; Amit Allahabadia; Jayne A Franklyn; Jaakko Tuomilehto; Eva Tuomilehto-Wolf; Francesco Cucca; Cristian Guja; Constantin Ionescu-Tirgoviste; Helen Stevens; Philippa Carr; Sarah Nutland; Patricia McKinney; Julian P Shield; William Wang; Heather J Cordell; Neil Walker; John A Todd; Patrick Concannon
Journal:  Nat Genet       Date:  2002-01-22       Impact factor: 38.330

Review 2.  Asthma genetics.

Authors:  William Osmond Charles Cookson
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

3.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

Authors:  J D Rioux; M J Daly; M S Silverberg; K Lindblad; H Steinhart; Z Cohen; T Delmonte; K Kocher; K Miller; S Guschwan; E J Kulbokas; S O'Leary; E Winchester; K Dewar; T Green; V Stone; C Chow; A Cohen; D Langelier; G Lapointe; D Gaudet; J Faith; N Branco; S B Bull; R S McLeod; A M Griffiths; A Bitton; G R Greenberg; E S Lander; K A Siminovitch; T J Hudson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

4.  CARD15 mutations in Blau syndrome.

Authors:  C Miceli-Richard; S Lesage; M Rybojad; A M Prieur; S Manouvrier-Hanu; R Häfner; M Chamaillard; H Zouali; G Thomas; J P Hugot
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 5.  The genetic jigsaw of inflammatory bowel disease.

Authors:  D A Watts; J Satsangi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure.

Authors:  Severine Vermeire; Gary Wild; Kerry Kocher; Josee Cousineau; Line Dufresne; Alain Bitton; Diane Langelier; Pierre Pare; Gilles Lapointe; Albert Cohen; Mark J Daly; John D Rioux
Journal:  Am J Hum Genet       Date:  2002-05-17       Impact factor: 11.025

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  23 in total

1.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance?

Authors:  A P Cuthbert; S A Fisher; C M Lewis; C G Mathew; J Sanderson; A Forbes
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  The promise and perils of interpreting genetic associations in Crohn's disease.

Authors:  T T Trinh; J D Rioux
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

4.  Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.

Authors:  Alexandra V Pearce; Sheila A Fisher; Natalie J Prescott; Clive M Onnie; Reenal Pattni; Peter Green; Alastair Forbes; John Mansfield; Jeremy Sanderson; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Int J Colorectal Dis       Date:  2006-05-31       Impact factor: 2.571

Review 5.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

6.  Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.

Authors:  Maria Gazouli; Gerassimos Mantzaris; Athanassios J Archimandritis; George Nasioulas; Nicholas P Anagnou
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

7.  Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Authors:  Toshihiko Okazaki; Ming-Hsi Wang; Patricia Rawsthorne; Michael Sargent; Lisa Wu Datta; Yin Yao Shugart; Charles N Bernstein; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

8.  IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.

Authors:  Elena Urcelay; Juan-Luis Mendoza; Alfonso Martinez; Laura Fernandez; Carlos Taxonera; Manuel Diaz-Rubio; Emilio-G de la Concha
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 9.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

10.  Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis.

Authors:  Dermot P B McGovern; David A Van Heel; Kenichi Negoro; Tariq Ahmad; Derek P Jewell
Journal:  Am J Hum Genet       Date:  2003-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.